| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0022-3476(98)70220-3 |
| P698 | PubMed publication ID | 9709705 |
| P2093 | author name string | R L Williams | |
| L C Lands | |||
| A L Coates | |||
| G M Davis | |||
| E W Outerbridge | |||
| L Hornby | |||
| S V Jacob | |||
| C F MacNeish | |||
| S P Riley | |||
| P2860 | cites work | Long term effects of artificial ventilation in neonates | Q68947952 |
| Diffusion capacity and oxygen desaturation effects on exercise in patients with cystic fibrosis | Q68987130 | ||
| Standardization of spirometry--1987 update. Statement of the American Thoracic Society | Q69438135 | ||
| Single breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique. Statement of the American Thoracic Society | Q69438139 | ||
| Cardiorespiratory status in long-term survivors of prematurity, with and without hyaline membrane disease | Q69528321 | ||
| Idiopathic respiratory distress syndrome. Recurrent respiratory illness in survivors | Q70372784 | ||
| Maternal asthma and idiopathic preterm labor | Q71551536 | ||
| Maximal static pressures in healthy children | Q71695678 | ||
| Diffusing capacity of the lung in school-aged children born very preterm, with and without bronchopulmonary dysplasia | Q71797211 | ||
| IMPROVED TECHNIQUE FOR ESTIMATING PLEURAL PRESSURE FROM ESOPHAGEAL BALLOONS | Q76837222 | ||
| Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia | Q28251863 | ||
| Lung function eight years after neonatal ventilation | Q35624195 | ||
| Lung function 8-18 years after intermittent positive pressure ventilation for hyaline membrane disease | Q36235359 | ||
| Long-term pulmonary sequelae of premature birth with and without idiopathic respiratory distress syndrome | Q43526398 | ||
| The long-term pulmonary sequelae of prematurity: the role of familial airway hyperreactivity and the respiratory distress syndrome | Q43680451 | ||
| Home oxygen therapy. Outcome of infants discharged from NICU on continuous treatment | Q46212799 | ||
| Pulmonary follow-up of moderately low birth weight infants with and without respiratory distress syndrome | Q47200293 | ||
| Severe bronchopulmonary dysplasia. Predictors of survival and outcome. | Q52091315 | ||
| Long-term follow-up of bronchopulmonary dysplasia. | Q52260951 | ||
| Ventilatory functions of normal children and young adults—Mexican-American, white, and black. I. Spirometry | Q52774126 | ||
| The diffusing capacity as a predictor of arterial oxygen desaturation during exercise in patients with chronic obstructive pulmonary disease. | Q54123858 | ||
| Late pulmonary sequelae of bronchopulmonary dysplasia | Q68613913 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bronchopulmonary dysplasia | Q922640 |
| P304 | page(s) | 193-200 | |
| P577 | publication date | 1998-08-01 | |
| P1433 | published in | The Journal of Pediatrics | Q7743611 |
| P1476 | title | Long-term pulmonary sequelae of severe bronchopulmonary dysplasia | |
| P478 | volume | 133 |
| Q64953639 | Biophysical and chemical stability of surfactant/budesonide and the pulmonary distribution following intra-tracheal administration. |
| Q28237555 | Bronchopulmonary dysplasia |
| Q37475664 | Curcumin protects the developing lung against long-term hyperoxic injury |
| Q35682680 | Discharge and aftercare in chronic lung disease of the newborn |
| Q47236476 | Effects of birthweight and oxygen supplementation on lung function in late childhood in children of very low birth weight |
| Q51720938 | Exhaled nitric oxide at school age in prematurely born infants with neonatal chronic lung disease. |
| Q24310245 | FGF-10 is decreased in bronchopulmonary dysplasia and suppressed by Toll-like receptor activation |
| Q45940168 | Fgf10 deficiency is causative for lethality in a mouse model of bronchopulmonary dysplasia. |
| Q24794925 | Inhaled corticosteroids for abnormal pulmonary function in children with a history of chronic lung disease of infancy: study protocol [ISRCTN55153521] |
| Q34187223 | Long term sequelae of bronchopulmonary dysplasia (chronic lung disease of infancy). |
| Q77112679 | Long-term pulmonary function studies in children with bronchopulmonary dysplasia: an ever-changing saga |
| Q64076114 | Maternal Tn Immunization Attenuates Hyperoxia-Induced Lung Injury in Neonatal Rats Through Suppression of Oxidative Stress and Inflammation |
| Q47239167 | Neonatal hyperoxia promotes asthma-like features through IL-33-dependent ILC2 responses |
| Q34502529 | Postnatal Infections and Immunology Affecting Chronic Lung Disease of Prematurity |
| Q51647712 | Pulmonary function and exercise capacity for ELBW survivors in preadolescence: effect of neonatal chronic lung disease |
| Q35291458 | Safety and efficacy of nitric oxide in chronic lung disease |
| Q73728754 | Statement on the care of the child with chronic lung disease of infancy and childhood |
| Q41248367 | Surfactant effects on the viability and function of human mesenchymal stem cells: in vitro and in vivo assessment |
| Q35632102 | Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial |
| Q28087007 | Understanding the Short- and Long-Term Respiratory Outcomes of Prematurity and Bronchopulmonary Dysplasia |
| Q48314093 | Upcycling umbilical cords: bridging regenerative medicine with neonatology |
| Q51694938 | Worsening of V'maxFRC in infants with chronic lung disease in the first year of life: a more favorable outcome after high-frequency oscillation ventilation. |
| Q74436787 | [Development in childhood (after age 3 years) through adulthood] |
| Q78819231 | [Difficult asthma in children] |
| Q81193546 | [Exercise alveolar hypoventilation in long-term survivors of bronchopulmonary dysplasia] |